The definitive directory of precision medicine and diagnostics companies advancing genomic testing, liquid biopsy, companion diagnostics, and personalized therapeutic decision-making. Curated for oncologists, pharma BD teams, clinical laboratorians, and healthcare systems evaluating precision medicine platforms.
Global leader in next-generation sequencing. Powers 90%+ of the world's genomic data across clinical diagnostics, research, and population-scale genomics.
Pioneer in liquid biopsy. Guardant360 CDx was the first FDA-approved liquid-only CGP test. Multi-year Merck collaboration for companion diagnostics.
Global leader in approved companion diagnostic indications. FoundationOne CDx and Liquid CDx for solid tumor CGP with decision support.
AI-powered precision medicine platform. Genomic sequencing, real-world evidence, and CDx across oncology, neuropsychiatry, and cardiology.
Leader in cfDNA testing. Signatera MRD assay for cancer recurrence monitoring. Scaling AI foundation models with NVIDIA.
Galleri multi-cancer early detection test. Methylation-based cfDNA detecting 50+ cancer types from a single blood draw. FDA PMA submitted.
Molecular profiling platform. MI Cancer Seek FDA-approved CDx. Precision Oncology Alliance of ~100 member institutions.
Leading oncology diagnostics lab. 500+ tests, NGS, IHC, FISH, CGP. 2M+ patient profiles. RaDaR ST MRD launching 2026.
Featured companies get full profiles with logos, test menus, capabilities, and backlinks visible to 86,757 biotech professionals. Become a data partner to stand out.
The featured companies above have full profiles, backlinks, and priority placement. The rest are names in a database. Learn how to upgrade your presence.
The BioMed Nexus Precision Medicine and Diagnostics Directory is the most comprehensive listing of companies advancing genomic testing, liquid biopsy, companion diagnostics, and personalized medicine. Updated regularly by our editorial team, this directory covers liquid biopsy developers, NGS platforms, companion diagnostic manufacturers, precision oncology tools, MRD and early detection innovators, rare disease genetic testing labs, and data analytics platforms.
Whether you are an oncologist evaluating genomic profiling options, a pharma BD team sourcing CDx partners, or a health system implementing precision medicine workflows, this directory provides the structured data and organization profiles you need to make informed decisions.
Companies can claim their free basic listing or upgrade to an Enhanced Profile or Full Landing Page for priority placement, backlinks, and permanent indexing on the BioMed Nexus domain. Contact our partnerships team to discuss listing options.
